China Pharma Holdings (CPHI) Q1 2025 Annual Earnings
CPHI·Reported May 21, 2025·Before market open
China Pharma Holdings reported Q1 2025 revenue of $1.14T (+122849308.0% YoY). Diluted EPS came in at $-0.70 (-900.0% YoY).
Revenue
$1.14T
Diluted EPS
$-0.70
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about China Pharma Holdings's Q1 2025 earnings report.
China Pharma Holdings (CPHI) reported Q1 2025 earnings on May 21, 2025 before market open.
China Pharma Holdings reported revenue of $1.14T and diluted EPS of $-0.70 for Q1 2025.
Compared to the same quarter a year prior, revenue grew 122849308.0% from $924.9K a year earlier and diluted EPS declined 900.0% from $-0.07.
You can read the 10-K periodic report (0001213900-25-026280) directly on SEC EDGAR. The filing index links above go to sec.gov.